Orthofix International reported $-123.88M in Pre-Tax Profit for its fiscal quarter ending in December of 2024.





Pre Tax Profit Change Date
AngioDynamics USD -4M 1.74M Feb/2025
AtriCure USD -86K 5.84M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
EDAP TMS EUR -4.91M 597K Sep/2025
Globus Medical USD 188.17M 84.5M Jun/2025
Hologic USD 229.7M 2.3M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 122.8M 94.4M Sep/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Medtronic USD 2.1B 224M Sep/2025
Mesa Laboratories USD -2.22M 6.03M Dec/2024
Orthofix International USD -123.88M 97.24M Dec/2024
Smith & Nephew USD 469M 70M Dec/2025
STAAR Surgical USD 18.79M 44.7M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Surmodics USD -7.51M 1.69M Sep/2024
Tandem Diabetes Care USD -57.72M 64.37M Jun/2025
Teleflex USD -438.58M 573.82M Sep/2025
Veracyte USD 18.89M 17.64M Sep/2025
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025